| Species |
hsa |
mmu |
mmu |
rno |
rno |
gga |
dre |
dre |
dme |
dme |
cel |
mcc |
cfa |
sce |
fca |
fca |
| Symbol |
PPP3R1 |
Ppp3r2 |
Ppp3r1 |
Ppp3r2 |
Ppp3r1 |
PPP3R1 |
ppp3r1b |
ppp3r1a |
CanB |
CanB2 |
cnb-1 |
PPP3R1 |
PPP3R1 |
CNB1 |
PPP3R2 |
PPP3R1 |
| Function* |
protein phosphatase 3 regulatory subunit B, alpha |
protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type II) |
protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I) |
protein phosphatase 3, regulatory subunit B, beta |
protein phosphatase 3, regulatory subunit B, alpha |
protein phosphatase 3 regulatory subunit B, alpha |
protein phosphatase 3 (formerly 2B), regulatory s1ubunit B, alpha isoform, b |
protein phosphatase 3, regulatory subunit B, alpha a |
Calcineurin B |
Calcineurin B2 |
Protein phosphatase 2B regulatory subunit cnb-1 |
protein phosphatase 3 regulatory subunit B, alpha |
protein phosphatase 3 regulatory subunit B, alpha |
calcineurin regulatory subunit B |
protein phosphatase 3 regulatory subunit B, beta |
protein phosphatase 3 regulatory subunit B, alpha |
| Expression |
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
| Umap |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Coexpression |
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| hsa04530 |
Tight junction |
4 |
 |
| hsa05130 |
Pathogenic Escherichia coli infection |
4 |
 |
| hsa04010 |
MAPK signaling pathway |
3 |
 |
| hsa04144 |
Endocytosis |
3 |
 |
| hsa04666 |
Fc gamma R-mediated phagocytosis |
3 |
 |
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| mmu03015 |
mRNA surveillance pathway |
2 |
|
| mmu03018 |
RNA degradation |
2 |
|
| mmu00561 |
Glycerolipid metabolism |
2 |
|
| mmu03320 |
PPAR signaling pathway |
2 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| mmu04114 |
Oocyte meiosis |
6 |
|
| mmu04810 |
Regulation of actin cytoskeleton |
5 |
|
| mmu05132 |
Salmonella infection |
5 |
|
| mmu05135 |
Yersinia infection |
5 |
|
| mmu04151 |
PI3K-Akt signaling pathway |
4 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| rno05014 |
Amyotrophic lateral sclerosis |
2 |
|
| rno05166 |
Human T-cell leukemia virus 1 infection |
2 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| rno04022 |
cGMP-PKG signaling pathway |
7 |
|
| rno04114 |
Oocyte meiosis |
6 |
|
| rno04218 |
Cellular senescence |
6 |
|
| rno04720 |
Long-term potentiation |
6 |
|
| rno04921 |
Oxytocin signaling pathway |
6 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| gga04010 |
MAPK signaling pathway |
4 |
|
| gga04310 |
Wnt signaling pathway |
4 |
|
| gga04020 |
Calcium signaling pathway |
3 |
|
| gga04114 |
Oocyte meiosis |
3 |
|
| gga04218 |
Cellular senescence |
2 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| dre05132 |
Salmonella infection |
4 |
|
| dre04144 |
Endocytosis |
3 |
|
| dre04110 |
Cell cycle |
2 |
|
| dre04310 |
Wnt signaling pathway |
2 |
|
| dre04010 |
MAPK signaling pathway |
2 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| dre04310 |
Wnt signaling pathway |
4 |
|
| dre04916 |
Melanogenesis |
4 |
|
| dre04012 |
ErbB signaling pathway |
3 |
|
| dre04020 |
Calcium signaling pathway |
3 |
|
| dre04114 |
Oocyte meiosis |
3 |
|
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| dme00510 |
N-Glycan biosynthesis |
2 |
|
| dme00513 |
Various types of N-glycan biosynthesis |
2 |
|
| dme04141 |
Protein processing in endoplasmic reticulum |
2 |
|
| dme04137 |
Mitophagy - animal |
2 |
|
| dme04310 |
Wnt signaling pathway |
2 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| cel04010 |
MAPK signaling pathway |
3 |
|
| cel04020 |
Calcium signaling pathway |
2 |
|
| cel04310 |
Wnt signaling pathway |
2 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| mcc04218 |
Cellular senescence |
2 |
|
| mcc04625 |
C-type lectin receptor signaling pathway |
2 |
|
| mcc05152 |
Tuberculosis |
2 |
|
| mcc05163 |
Human cytomegalovirus infection |
2 |
|
| mcc04144 |
Endocytosis |
2 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| cfa04144 |
Endocytosis |
6 |
|
| cfa04962 |
Vasopressin-regulated water reabsorption |
3 |
|
| cfa05152 |
Tuberculosis |
3 |
|
| cfa04140 |
Autophagy - animal |
3 |
|
| cfa05014 |
Amyotrophic lateral sclerosis |
3 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| sce04144 |
Endocytosis |
4 |
|
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| fca05010 |
Alzheimer disease |
4 |
|
| fca05014 |
Amyotrophic lateral sclerosis |
4 |
|
| fca05020 |
Prion disease |
4 |
|
| fca05022 |
Pathways of neurodegeneration - multiple diseases |
4 |
|
| fca04010 |
MAPK signaling pathway |
3 |
|
|
| GO BP* |
|
GO:0060487 [L] [N] lung epithelial cell differentiation
|
(8 genes)
|
|
GO:0099170 [L] [N] postsynaptic modulation of chemical synaptic transmission
|
(9 genes)
|
|
GO:0099149 [L] [N] regulation of postsynaptic neurotransmitter receptor internalization
|
(11 genes)
|
|
GO:0033173 [L] [N] calcineurin-NFAT signaling cascade
|
(12 genes)
|
|
GO:0022011 [L] [N] myelination in peripheral nervous system
|
(17 genes)
|
|
GO:1900740 [L] [N] positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway
|
(26 genes)
|
|
GO:0001569 [L] [N] branching involved in blood vessel morphogenesis
|
(31 genes)
|
|
GO:0007223 [L] [N] Wnt signaling pathway, calcium modulating pathway
|
(37 genes)
|
|
GO:0043666 [L] [N] regulation of phosphoprotein phosphatase activity
|
(43 genes)
|
|
GO:0001837 [L] [N] epithelial to mesenchymal transition
|
(46 genes)
|
|
GO:0006606 [L] [N] protein import into nucleus
|
(79 genes)
|
|
GO:0006470 [L] [N] protein dephosphorylation
|
(148 genes)
|
|
GO:0038095 [L] [N] Fc-epsilon receptor signaling pathway
|
(168 genes)
|
|
GO:0007507 [L] [N] heart development
|
(199 genes)
|
|
GO:0045944 [L] [N] positive regulation of transcription by RNA polymerase II
|
(1124 genes)
|
|
|
GO:0007321 [L] [N] sperm displacement
|
(1 genes)
|
|
GO:0005977 [L] [N] glycogen metabolic process
|
(39 genes)
|
|
GO:0006952 [L] [N] defense response
|
(134 genes)
|
|
|
GO:0014044 [L] [N] Schwann cell development
|
(11 genes)
|
|
GO:0033173 [L] [N] calcineurin-NFAT signaling cascade
|
(12 genes)
|
|
GO:0099170 [L] [N] postsynaptic modulation of chemical synaptic transmission
|
(12 genes)
|
|
GO:0060487 [L] [N] lung epithelial cell differentiation
|
(13 genes)
|
|
GO:0022011 [L] [N] myelination in peripheral nervous system
|
(23 genes)
|
|
GO:0099149 [L] [N] regulation of postsynaptic neurotransmitter receptor internalization
|
(23 genes)
|
|
GO:0001569 [L] [N] branching involved in blood vessel morphogenesis
|
(41 genes)
|
|
GO:0001837 [L] [N] epithelial to mesenchymal transition
|
(41 genes)
|
|
GO:0034504 [L] [N] protein localization to nucleus
|
(46 genes)
|
|
GO:0006606 [L] [N] protein import into nucleus
|
(100 genes)
|
|
GO:0006470 [L] [N] protein dephosphorylation
|
(142 genes)
|
|
GO:0007507 [L] [N] heart development
|
(261 genes)
|
|
GO:0045944 [L] [N] positive regulation of transcription by RNA polymerase II
|
(1172 genes)
|
|
|
GO:0043666 [L] [N] regulation of phosphoprotein phosphatase activity
|
(40 genes)
|
|
|
GO:0014044 [L] [N] Schwann cell development
|
(12 genes)
|
|
GO:0033173 [L] [N] calcineurin-NFAT signaling cascade
|
(12 genes)
|
|
GO:0099170 [L] [N] postsynaptic modulation of chemical synaptic transmission
|
(12 genes)
|
|
GO:0060487 [L] [N] lung epithelial cell differentiation
|
(13 genes)
|
|
GO:0022011 [L] [N] myelination in peripheral nervous system
|
(23 genes)
|
|
GO:0099149 [L] [N] regulation of postsynaptic neurotransmitter receptor internalization
|
(24 genes)
|
|
GO:0001569 [L] [N] branching involved in blood vessel morphogenesis
|
(37 genes)
|
|
GO:0043666 [L] [N] regulation of phosphoprotein phosphatase activity
|
(40 genes)
|
|
GO:0001837 [L] [N] epithelial to mesenchymal transition
|
(42 genes)
|
|
GO:0034504 [L] [N] protein localization to nucleus
|
(46 genes)
|
|
GO:0006606 [L] [N] protein import into nucleus
|
(92 genes)
|
|
GO:0006470 [L] [N] protein dephosphorylation
|
(138 genes)
|
|
GO:0007507 [L] [N] heart development
|
(308 genes)
|
|
GO:0045944 [L] [N] positive regulation of transcription by RNA polymerase II
|
(1199 genes)
|
|
|
|
|
|
GO:0030431 [L] [N] sleep
|
(49 genes)
|
|
GO:0007269 [L] [N] neurotransmitter secretion
|
(63 genes)
|
|
GO:0006470 [L] [N] protein dephosphorylation
|
(89 genes)
|
|
GO:0016192 [L] [N] vesicle-mediated transport
|
(137 genes)
|
|
|
GO:0030241 [L] [N] skeletal muscle myosin thick filament assembly
|
(3 genes)
|
|
GO:0051321 [L] [N] meiotic cell cycle
|
(29 genes)
|
|
GO:0045214 [L] [N] sarcomere organization
|
(33 genes)
|
|
GO:0030431 [L] [N] sleep
|
(49 genes)
|
|
GO:0007269 [L] [N] neurotransmitter secretion
|
(63 genes)
|
|
GO:0006470 [L] [N] protein dephosphorylation
|
(89 genes)
|
|
GO:0016192 [L] [N] vesicle-mediated transport
|
(137 genes)
|
|
|
GO:0043666 [L] [N] regulation of phosphoprotein phosphatase activity
|
(17 genes)
|
|
GO:0006897 [L] [N] endocytosis
|
(101 genes)
|
|
|
|
|
GO:0006873 [L] [N] cellular ion homeostasis
|
(13 genes)
|
|
GO:0000754 [L] [N] adaptation of signaling pathway by response to pheromone involved in conjugation with cellular fusion
|
(14 genes)
|
|
GO:0006470 [L] [N] protein dephosphorylation
|
(56 genes)
|
|
GO:0031505 [L] [N] fungal-type cell wall organization
|
(135 genes)
|
|
GO:0050790 [L] [N] regulation of catalytic activity
|
(177 genes)
|
|
|
|
| GO CC* |
|
GO:0005955 [L] [N] calcineurin complex
|
(5 genes)
|
|
GO:0098688 [L] [N] parallel fiber to Purkinje cell synapse
|
(14 genes)
|
|
GO:0098685 [L] [N] Schaffer collateral - CA1 synapse
|
(78 genes)
|
|
GO:0098794 [L] [N] postsynapse
|
(95 genes)
|
|
GO:0042383 [L] [N] sarcolemma
|
(101 genes)
|
|
GO:0098978 [L] [N] glutamatergic synapse
|
(333 genes)
|
|
GO:0005739 [L] [N] mitochondrion
|
(1320 genes)
|
|
GO:0005654 [L] [N] nucleoplasm
|
(3806 genes)
|
|
GO:0005829 [L] [N] cytosol
|
(5289 genes)
|
|
|
|
GO:0005955 [L] [N] calcineurin complex
|
(5 genes)
|
|
GO:0098688 [L] [N] parallel fiber to Purkinje cell synapse
|
(33 genes)
|
|
GO:0098685 [L] [N] Schaffer collateral - CA1 synapse
|
(115 genes)
|
|
GO:0042383 [L] [N] sarcolemma
|
(124 genes)
|
|
GO:0098978 [L] [N] glutamatergic synapse
|
(518 genes)
|
|
GO:0045202 [L] [N] synapse
|
(763 genes)
|
|
GO:0005829 [L] [N] cytosol
|
(3688 genes)
|
|
GO:0005886 [L] [N] plasma membrane
|
(4367 genes)
|
|
GO:0016020 [L] [N] membrane
|
(6651 genes)
|
|
GO:0005737 [L] [N] cytoplasm
|
(6992 genes)
|
|
|
GO:0005829 [L] [N] cytosol
|
(3517 genes)
|
|
|
GO:0005955 [L] [N] calcineurin complex
|
(5 genes)
|
|
GO:0098688 [L] [N] parallel fiber to Purkinje cell synapse
|
(33 genes)
|
|
GO:0098685 [L] [N] Schaffer collateral - CA1 synapse
|
(117 genes)
|
|
GO:0042383 [L] [N] sarcolemma
|
(136 genes)
|
|
GO:0098794 [L] [N] postsynapse
|
(165 genes)
|
|
GO:0098978 [L] [N] glutamatergic synapse
|
(518 genes)
|
|
GO:0045202 [L] [N] synapse
|
(592 genes)
|
|
GO:0005829 [L] [N] cytosol
|
(3517 genes)
|
|
|
|
|
|
GO:0005955 [L] [N] calcineurin complex
|
(7 genes)
|
|
GO:0008021 [L] [N] synaptic vesicle
|
(65 genes)
|
|
|
GO:0005955 [L] [N] calcineurin complex
|
(7 genes)
|
|
GO:0008021 [L] [N] synaptic vesicle
|
(65 genes)
|
|
|
GO:0030017 [L] [N] sarcomere
|
(24 genes)
|
|
GO:0055120 [L] [N] striated muscle dense body
|
(96 genes)
|
|
GO:0005783 [L] [N] endoplasmic reticulum
|
(382 genes)
|
|
GO:0005737 [L] [N] cytoplasm
|
(2113 genes)
|
|
|
|
|
GO:0005955 [L] [N] calcineurin complex
|
(3 genes)
|
|
|
|
| GO MF* |
|
GO:0004723 [L] [N] calcium-dependent protein serine/threonine phosphatase activity
|
(2 genes)
|
|
GO:0008597 [L] [N] calcium-dependent protein serine/threonine phosphatase regulator activity
|
(5 genes)
|
|
GO:0016018 [L] [N] cyclosporin A binding
|
(24 genes)
|
|
GO:0019902 [L] [N] phosphatase binding
|
(50 genes)
|
|
GO:0005516 [L] [N] calmodulin binding
|
(200 genes)
|
|
GO:0019904 [L] [N] protein domain specific binding
|
(245 genes)
|
|
GO:0005509 [L] [N] calcium ion binding
|
(712 genes)
|
|
GO:0005515 [L] [N] protein binding
|
(12443 genes)
|
|
|
GO:0004723 [L] [N] calcium-dependent protein serine/threonine phosphatase activity
|
(4 genes)
|
|
GO:0008597 [L] [N] calcium-dependent protein serine/threonine phosphatase regulator activity
|
(5 genes)
|
|
GO:0005509 [L] [N] calcium ion binding
|
(634 genes)
|
|
GO:0046872 [L] [N] metal ion binding
|
(3144 genes)
|
|
|
GO:0008597 [L] [N] calcium-dependent protein serine/threonine phosphatase regulator activity
|
(5 genes)
|
|
GO:0016018 [L] [N] cyclosporin A binding
|
(13 genes)
|
|
GO:0019902 [L] [N] phosphatase binding
|
(55 genes)
|
|
GO:0004721 [L] [N] phosphoprotein phosphatase activity
|
(141 genes)
|
|
GO:0019904 [L] [N] protein domain specific binding
|
(332 genes)
|
|
GO:0019899 [L] [N] enzyme binding
|
(471 genes)
|
|
GO:0005509 [L] [N] calcium ion binding
|
(634 genes)
|
|
GO:0046872 [L] [N] metal ion binding
|
(3144 genes)
|
|
GO:0005515 [L] [N] protein binding
|
(5298 genes)
|
|
|
GO:0008597 [L] [N] calcium-dependent protein serine/threonine phosphatase regulator activity
|
(5 genes)
|
|
GO:0005509 [L] [N] calcium ion binding
|
(673 genes)
|
|
GO:0005515 [L] [N] protein binding
|
(1723 genes)
|
|
|
GO:0008597 [L] [N] calcium-dependent protein serine/threonine phosphatase regulator activity
|
(5 genes)
|
|
GO:0016018 [L] [N] cyclosporin A binding
|
(19 genes)
|
|
GO:0004721 [L] [N] phosphoprotein phosphatase activity
|
(48 genes)
|
|
GO:0019902 [L] [N] phosphatase binding
|
(55 genes)
|
|
GO:0019904 [L] [N] protein domain specific binding
|
(342 genes)
|
|
GO:0019899 [L] [N] enzyme binding
|
(442 genes)
|
|
GO:0005509 [L] [N] calcium ion binding
|
(673 genes)
|
|
GO:0005515 [L] [N] protein binding
|
(1723 genes)
|
|
|
|
GO:0008597 [L] [N] calcium-dependent protein serine/threonine phosphatase regulator activity
|
(5 genes)
|
|
GO:0005509 [L] [N] calcium ion binding
|
(683 genes)
|
|
|
GO:0008597 [L] [N] calcium-dependent protein serine/threonine phosphatase regulator activity
|
(5 genes)
|
|
GO:0005509 [L] [N] calcium ion binding
|
(683 genes)
|
|
|
GO:0008597 [L] [N] calcium-dependent protein serine/threonine phosphatase regulator activity
|
(3 genes)
|
|
GO:0005516 [L] [N] calmodulin binding
|
(41 genes)
|
|
GO:0005509 [L] [N] calcium ion binding
|
(202 genes)
|
|
|
GO:0008597 [L] [N] calcium-dependent protein serine/threonine phosphatase regulator activity
|
(3 genes)
|
|
GO:0005516 [L] [N] calmodulin binding
|
(41 genes)
|
|
GO:0005509 [L] [N] calcium ion binding
|
(202 genes)
|
|
GO:0005515 [L] [N] protein binding
|
(889 genes)
|
|
|
GO:0008597 [L] [N] calcium-dependent protein serine/threonine phosphatase regulator activity
|
(2 genes)
|
|
GO:0005509 [L] [N] calcium ion binding
|
(173 genes)
|
|
GO:0046872 [L] [N] metal ion binding
|
(1603 genes)
|
|
|
|
|
GO:0008597 [L] [N] calcium-dependent protein serine/threonine phosphatase regulator activity
|
(2 genes)
|
|
GO:0004723 [L] [N] calcium-dependent protein serine/threonine phosphatase activity
|
(3 genes)
|
|
GO:0005509 [L] [N] calcium ion binding
|
(28 genes)
|
|
GO:0046872 [L] [N] metal ion binding
|
(789 genes)
|
|
|
|
| KEGG* |
| 04010 |
MAPK signaling pathway |
 |
| 04020 |
Calcium signaling pathway |
|
| 04022 |
cGMP-PKG signaling pathway |
|
| 04114 |
Oocyte meiosis |
|
| 04218 |
Cellular senescence |
|
| 04310 |
Wnt signaling pathway |
|
| 04360 |
Axon guidance |
|
| 04370 |
VEGF signaling pathway |
|
| 04380 |
Osteoclast differentiation |
|
| 04625 |
C-type lectin receptor signaling pathway |
|
| 04650 |
Natural killer cell mediated cytotoxicity |
|
| 04658 |
Th1 and Th2 cell differentiation |
|
| 04659 |
Th17 cell differentiation |
|
| 04660 |
T cell receptor signaling pathway |
|
| 04662 |
B cell receptor signaling pathway |
|
| 04720 |
Long-term potentiation |
|
| 04724 |
Glutamatergic synapse |
|
| 04921 |
Oxytocin signaling pathway |
|
| 04922 |
Glucagon signaling pathway |
|
| 04924 |
Renin secretion |
|
| 05010 |
Alzheimer disease |
|
| 05014 |
Amyotrophic lateral sclerosis |
|
| 05020 |
Prion disease |
|
| 05022 |
Pathways of neurodegeneration - multiple diseases |
|
| 05031 |
Amphetamine addiction |
|
| 05152 |
Tuberculosis |
|
| 05163 |
Human cytomegalovirus infection |
|
| 05166 |
Human T-cell leukemia virus 1 infection |
|
| 05167 |
Kaposi sarcoma-associated herpesvirus infection |
|
| 05170 |
Human immunodeficiency virus 1 infection |
|
| 05235 |
PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
| 05417 |
Lipid and atherosclerosis |
|
|
| 04010 |
MAPK signaling pathway |
|
| 04020 |
Calcium signaling pathway |
|
| 04022 |
cGMP-PKG signaling pathway |
|
| 04114 |
Oocyte meiosis |
|
| 04218 |
Cellular senescence |
|
| 04310 |
Wnt signaling pathway |
|
| 04360 |
Axon guidance |
|
| 04370 |
VEGF signaling pathway |
|
| 04380 |
Osteoclast differentiation |
|
| 04625 |
C-type lectin receptor signaling pathway |
|
| 04650 |
Natural killer cell mediated cytotoxicity |
|
| 04658 |
Th1 and Th2 cell differentiation |
|
| 04659 |
Th17 cell differentiation |
|
| 04660 |
T cell receptor signaling pathway |
|
| 04662 |
B cell receptor signaling pathway |
|
| 04720 |
Long-term potentiation |
|
| 04724 |
Glutamatergic synapse |
|
| 04921 |
Oxytocin signaling pathway |
|
| 04922 |
Glucagon signaling pathway |
|
| 04924 |
Renin secretion |
|
| 05010 |
Alzheimer disease |
|
| 05014 |
Amyotrophic lateral sclerosis |
|
| 05020 |
Prion disease |
|
| 05022 |
Pathways of neurodegeneration - multiple diseases |
|
| 05031 |
Amphetamine addiction |
|
| 05152 |
Tuberculosis |
|
| 05163 |
Human cytomegalovirus infection |
|
| 05166 |
Human T-cell leukemia virus 1 infection |
|
| 05167 |
Kaposi sarcoma-associated herpesvirus infection |
|
| 05170 |
Human immunodeficiency virus 1 infection |
|
| 05235 |
PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
| 05417 |
Lipid and atherosclerosis |
|
|
| 04010 |
MAPK signaling pathway |
|
| 04020 |
Calcium signaling pathway |
|
| 04022 |
cGMP-PKG signaling pathway |
|
| 04114 |
Oocyte meiosis |
|
| 04218 |
Cellular senescence |
|
| 04310 |
Wnt signaling pathway |
|
| 04360 |
Axon guidance |
|
| 04370 |
VEGF signaling pathway |
|
| 04380 |
Osteoclast differentiation |
|
| 04625 |
C-type lectin receptor signaling pathway |
|
| 04650 |
Natural killer cell mediated cytotoxicity |
|
| 04658 |
Th1 and Th2 cell differentiation |
|
| 04659 |
Th17 cell differentiation |
|
| 04660 |
T cell receptor signaling pathway |
|
| 04662 |
B cell receptor signaling pathway |
|
| 04720 |
Long-term potentiation |
|
| 04724 |
Glutamatergic synapse |
|
| 04921 |
Oxytocin signaling pathway |
|
| 04922 |
Glucagon signaling pathway |
|
| 04924 |
Renin secretion |
|
| 05010 |
Alzheimer disease |
|
| 05014 |
Amyotrophic lateral sclerosis |
|
| 05020 |
Prion disease |
|
| 05022 |
Pathways of neurodegeneration - multiple diseases |
|
| 05031 |
Amphetamine addiction |
|
| 05152 |
Tuberculosis |
|
| 05163 |
Human cytomegalovirus infection |
|
| 05166 |
Human T-cell leukemia virus 1 infection |
|
| 05167 |
Kaposi sarcoma-associated herpesvirus infection |
|
| 05170 |
Human immunodeficiency virus 1 infection |
|
| 05235 |
PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
| 05417 |
Lipid and atherosclerosis |
|
|
| 04010 |
MAPK signaling pathway |
|
| 04020 |
Calcium signaling pathway |
|
| 04022 |
cGMP-PKG signaling pathway |
|
| 04114 |
Oocyte meiosis |
|
| 04218 |
Cellular senescence |
|
| 04310 |
Wnt signaling pathway |
|
| 04360 |
Axon guidance |
|
| 04370 |
VEGF signaling pathway |
|
| 04380 |
Osteoclast differentiation |
|
| 04625 |
C-type lectin receptor signaling pathway |
|
| 04650 |
Natural killer cell mediated cytotoxicity |
|
| 04658 |
Th1 and Th2 cell differentiation |
|
| 04659 |
Th17 cell differentiation |
|
| 04660 |
T cell receptor signaling pathway |
|
| 04662 |
B cell receptor signaling pathway |
|
| 04720 |
Long-term potentiation |
|
| 04724 |
Glutamatergic synapse |
|
| 04921 |
Oxytocin signaling pathway |
|
| 04922 |
Glucagon signaling pathway |
|
| 04924 |
Renin secretion |
|
| 05010 |
Alzheimer disease |
|
| 05014 |
Amyotrophic lateral sclerosis |
|
| 05020 |
Prion disease |
|
| 05022 |
Pathways of neurodegeneration - multiple diseases |
|
| 05031 |
Amphetamine addiction |
|
| 05152 |
Tuberculosis |
|
| 05163 |
Human cytomegalovirus infection |
|
| 05166 |
Human T-cell leukemia virus 1 infection |
|
| 05167 |
Kaposi sarcoma-associated herpesvirus infection |
|
| 05170 |
Human immunodeficiency virus 1 infection |
|
| 05235 |
PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
| 05417 |
Lipid and atherosclerosis |
|
|
| 04010 |
MAPK signaling pathway |
|
| 04020 |
Calcium signaling pathway |
|
| 04022 |
cGMP-PKG signaling pathway |
|
| 04114 |
Oocyte meiosis |
|
| 04218 |
Cellular senescence |
|
| 04310 |
Wnt signaling pathway |
|
| 04360 |
Axon guidance |
|
| 04370 |
VEGF signaling pathway |
|
| 04380 |
Osteoclast differentiation |
|
| 04625 |
C-type lectin receptor signaling pathway |
|
| 04650 |
Natural killer cell mediated cytotoxicity |
|
| 04658 |
Th1 and Th2 cell differentiation |
|
| 04659 |
Th17 cell differentiation |
|
| 04660 |
T cell receptor signaling pathway |
|
| 04662 |
B cell receptor signaling pathway |
|
| 04720 |
Long-term potentiation |
|
| 04724 |
Glutamatergic synapse |
|
| 04921 |
Oxytocin signaling pathway |
|
| 04922 |
Glucagon signaling pathway |
|
| 04924 |
Renin secretion |
|
| 05010 |
Alzheimer disease |
|
| 05014 |
Amyotrophic lateral sclerosis |
|
| 05020 |
Prion disease |
|
| 05022 |
Pathways of neurodegeneration - multiple diseases |
|
| 05031 |
Amphetamine addiction |
|
| 05152 |
Tuberculosis |
|
| 05163 |
Human cytomegalovirus infection |
|
| 05166 |
Human T-cell leukemia virus 1 infection |
|
| 05167 |
Kaposi sarcoma-associated herpesvirus infection |
|
| 05170 |
Human immunodeficiency virus 1 infection |
|
| 05235 |
PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
| 05417 |
Lipid and atherosclerosis |
|
|
| 04010 |
MAPK signaling pathway |
|
| 04020 |
Calcium signaling pathway |
|
| 04114 |
Oocyte meiosis |
|
| 04218 |
Cellular senescence |
|
| 04310 |
Wnt signaling pathway |
|
| 04370 |
VEGF signaling pathway |
|
| 04625 |
C-type lectin receptor signaling pathway |
|
|
| 04010 |
MAPK signaling pathway |
|
| 04020 |
Calcium signaling pathway |
|
| 04114 |
Oocyte meiosis |
|
| 04218 |
Cellular senescence |
|
| 04310 |
Wnt signaling pathway |
|
| 04370 |
VEGF signaling pathway |
|
| 04625 |
C-type lectin receptor signaling pathway |
|
|
| 04010 |
MAPK signaling pathway |
|
| 04020 |
Calcium signaling pathway |
|
| 04114 |
Oocyte meiosis |
|
| 04218 |
Cellular senescence |
|
| 04310 |
Wnt signaling pathway |
|
| 04370 |
VEGF signaling pathway |
|
| 04625 |
C-type lectin receptor signaling pathway |
|
|
| 04310 |
Wnt signaling pathway |
|
|
| 04310 |
Wnt signaling pathway |
|
|
| 04010 |
MAPK signaling pathway |
|
| 04020 |
Calcium signaling pathway |
|
| 04310 |
Wnt signaling pathway |
|
|
| 04010 |
MAPK signaling pathway |
|
| 04020 |
Calcium signaling pathway |
|
| 04022 |
cGMP-PKG signaling pathway |
|
| 04114 |
Oocyte meiosis |
|
| 04218 |
Cellular senescence |
|
| 04310 |
Wnt signaling pathway |
|
| 04360 |
Axon guidance |
|
| 04370 |
VEGF signaling pathway |
|
| 04380 |
Osteoclast differentiation |
|
| 04625 |
C-type lectin receptor signaling pathway |
|
| 04650 |
Natural killer cell mediated cytotoxicity |
|
| 04658 |
Th1 and Th2 cell differentiation |
|
| 04659 |
Th17 cell differentiation |
|
| 04660 |
T cell receptor signaling pathway |
|
| 04662 |
B cell receptor signaling pathway |
|
| 04720 |
Long-term potentiation |
|
| 04724 |
Glutamatergic synapse |
|
| 04921 |
Oxytocin signaling pathway |
|
| 04922 |
Glucagon signaling pathway |
|
| 04924 |
Renin secretion |
|
| 05010 |
Alzheimer disease |
|
| 05014 |
Amyotrophic lateral sclerosis |
|
| 05020 |
Prion disease |
|
| 05022 |
Pathways of neurodegeneration - multiple diseases |
|
| 05031 |
Amphetamine addiction |
|
| 05152 |
Tuberculosis |
|
| 05163 |
Human cytomegalovirus infection |
|
| 05166 |
Human T-cell leukemia virus 1 infection |
|
| 05167 |
Kaposi sarcoma-associated herpesvirus infection |
|
| 05170 |
Human immunodeficiency virus 1 infection |
|
| 05235 |
PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
| 05417 |
Lipid and atherosclerosis |
|
|
| 04010 |
MAPK signaling pathway |
|
| 04020 |
Calcium signaling pathway |
|
| 04022 |
cGMP-PKG signaling pathway |
|
| 04114 |
Oocyte meiosis |
|
| 04218 |
Cellular senescence |
|
| 04310 |
Wnt signaling pathway |
|
| 04360 |
Axon guidance |
|
| 04370 |
VEGF signaling pathway |
|
| 04380 |
Osteoclast differentiation |
|
| 04625 |
C-type lectin receptor signaling pathway |
|
| 04650 |
Natural killer cell mediated cytotoxicity |
|
| 04658 |
Th1 and Th2 cell differentiation |
|
| 04659 |
Th17 cell differentiation |
|
| 04660 |
T cell receptor signaling pathway |
|
| 04662 |
B cell receptor signaling pathway |
|
| 04720 |
Long-term potentiation |
|
| 04724 |
Glutamatergic synapse |
|
| 04921 |
Oxytocin signaling pathway |
|
| 04922 |
Glucagon signaling pathway |
|
| 04924 |
Renin secretion |
|
| 05010 |
Alzheimer disease |
|
| 05014 |
Amyotrophic lateral sclerosis |
|
| 05020 |
Prion disease |
|
| 05022 |
Pathways of neurodegeneration - multiple diseases |
|
| 05031 |
Amphetamine addiction |
|
| 05152 |
Tuberculosis |
|
| 05163 |
Human cytomegalovirus infection |
|
| 05166 |
Human T-cell leukemia virus 1 infection |
|
| 05167 |
Kaposi sarcoma-associated herpesvirus infection |
|
| 05170 |
Human immunodeficiency virus 1 infection |
|
| 05235 |
PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
| 05417 |
Lipid and atherosclerosis |
|
|
|
| 04010 |
MAPK signaling pathway |
|
| 04020 |
Calcium signaling pathway |
|
| 04022 |
cGMP-PKG signaling pathway |
|
| 04114 |
Oocyte meiosis |
|
| 04218 |
Cellular senescence |
|
| 04310 |
Wnt signaling pathway |
|
| 04360 |
Axon guidance |
|
| 04370 |
VEGF signaling pathway |
|
| 04380 |
Osteoclast differentiation |
|
| 04625 |
C-type lectin receptor signaling pathway |
|
| 04650 |
Natural killer cell mediated cytotoxicity |
|
| 04658 |
Th1 and Th2 cell differentiation |
|
| 04659 |
Th17 cell differentiation |
|
| 04660 |
T cell receptor signaling pathway |
|
| 04662 |
B cell receptor signaling pathway |
|
| 04720 |
Long-term potentiation |
|
| 04724 |
Glutamatergic synapse |
|
| 04921 |
Oxytocin signaling pathway |
|
| 04922 |
Glucagon signaling pathway |
|
| 04924 |
Renin secretion |
|
| 05010 |
Alzheimer disease |
|
| 05014 |
Amyotrophic lateral sclerosis |
|
| 05020 |
Prion disease |
|
| 05022 |
Pathways of neurodegeneration - multiple diseases |
|
| 05031 |
Amphetamine addiction |
|
| 05152 |
Tuberculosis |
|
| 05163 |
Human cytomegalovirus infection |
|
| 05166 |
Human T-cell leukemia virus 1 infection |
|
| 05167 |
Kaposi sarcoma-associated herpesvirus infection |
|
| 05170 |
Human immunodeficiency virus 1 infection |
|
| 05235 |
PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
| 05417 |
Lipid and atherosclerosis |
|
|
| 04010 |
MAPK signaling pathway |
|
| 04020 |
Calcium signaling pathway |
|
| 04022 |
cGMP-PKG signaling pathway |
|
| 04114 |
Oocyte meiosis |
|
| 04218 |
Cellular senescence |
|
| 04310 |
Wnt signaling pathway |
|
| 04360 |
Axon guidance |
|
| 04370 |
VEGF signaling pathway |
|
| 04380 |
Osteoclast differentiation |
|
| 04625 |
C-type lectin receptor signaling pathway |
|
| 04650 |
Natural killer cell mediated cytotoxicity |
|
| 04658 |
Th1 and Th2 cell differentiation |
|
| 04659 |
Th17 cell differentiation |
|
| 04660 |
T cell receptor signaling pathway |
|
| 04662 |
B cell receptor signaling pathway |
|
| 04720 |
Long-term potentiation |
|
| 04724 |
Glutamatergic synapse |
|
| 04921 |
Oxytocin signaling pathway |
|
| 04922 |
Glucagon signaling pathway |
|
| 04924 |
Renin secretion |
|
| 05010 |
Alzheimer disease |
|
| 05014 |
Amyotrophic lateral sclerosis |
|
| 05020 |
Prion disease |
|
| 05022 |
Pathways of neurodegeneration - multiple diseases |
|
| 05031 |
Amphetamine addiction |
|
| 05152 |
Tuberculosis |
|
| 05163 |
Human cytomegalovirus infection |
|
| 05166 |
Human T-cell leukemia virus 1 infection |
|
| 05167 |
Kaposi sarcoma-associated herpesvirus infection |
|
| 05170 |
Human immunodeficiency virus 1 infection |
|
| 05235 |
PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
| 05417 |
Lipid and atherosclerosis |
|
|
| Entrez Gene ID* |
5534 |
19059 |
19058 |
29749 |
29748 |
378804 |
447814 |
564337 |
44317 |
46456 |
179572 |
100428682 |
612559 |
853644 |
101097765 |
101090344 |
